With over 35 years of experience, Shroff Consulting Engineers has built a strong track record across the pharmaceutical, chemical, and petrochemical sectors
Jayesh Shroff, Managing Director
The pharmaceutical engineering and design consulting industry plays a pivotal role in shaping the backbone of global healthcare. As demand for new drugs, generics, and advanced therapies continues to surge, pharmaceutical companies are under increasing pressure to build facilities that are efficient, compliant, and future-ready.
Today’s manufacturing plants must adhere to stringent international regulatory standards while incorporating advanced technologies, sustainability practices, and scalable designs. In India, this transformation is further accelerated by the government’s push toward self-reliance and the country’s growing reputation as a global pharmaceutical hub.
As companies expand their manufacturing capabilities and reduce dependence on imports, the need for specialized engineering expertise has grown significantly. In this dynamic and evolving landscape, Shroff Consulting Engineers has established itself as a key contributor, delivering high-quality, compliant, and innovative engineering solutions that align with both domestic and global expectations. Shroff’s plant designs are approvable by Regulatory Authorities like USFDA, MHRA, and more.
End-to-End Engineering Excellence Across the Project Lifecycle
Shroff Consulting Engineers distinguishes itself through its comprehensive approach to project execution, offering services that span the entire lifecycle of pharmaceutical and chemical manufacturing facilities.
The company begins with conceptual design and project cost estimation, ensuring that clients have a clear and practical roadmap from the outset. It further supports clients in selecting appropriate technologies, evaluating equipment, and conducting trials to ensure optimal performance.
A major strength of the organization lies in its ability to scale up processes from research and development stages to full production. This includes process engineering, simulation, and recovery system design, all of which are critical for achieving efficiency and cost-effectiveness.
On the detailed engineering front, Shroff delivers integrated solutions covering architectural, civil, and structural design, supported by advanced 3D modeling and piping layouts.
The inclusion of specialized systems such as HVAC, cleanrooms, electrical infrastructure, and automation ensures that facilities meet the stringent requirements of pharmaceutical manufacturing. Additionally, the company provides procurement support, construction management, and project management services, creating a seamless and coordinated execution framework.
Addressing Industry Challenges Through Standardization and Expertise
The pharmaceutical sector today faces several challenges when it comes to building or upgrading manufacturing facilities. One of the most significant issues is the shortage of skilled engineers and designers who possess the expertise required to meet complex regulatory and technical standards.
At the same time, rising costs of plant and machinery have increased capital investment requirements, particularly in the generic drug segment where returns can take longer to materialize. Construction delays caused by a lack of skilled labor further complicate project timelines.
With over 35 years of experience, Shroff Consulting Engineers has built a strong track record across the pharmaceutical, chemical, and petrochemical sectorsJayesh Shroff, Managing Director
Shroff Consulting Engineers has proactively addressed these challenges by focusing on standardization and knowledge-driven practices. The company has developed standardized design frameworks for pharmaceutical and chemical projects, ensuring that all outputs are compliant with regulatory requirements and industry best practices. This approach not only enhances efficiency but also minimizes risks associated with non-compliance.
Equally important is the firm’s emphasis on experience and continuous learning. Its team of professionals remains updated on evolving global standards, enabling the company to deliver solutions that meet stringent regulatory expectations. When required, Shroff collaborates with specialized consultants for GMP compliance, ensuring that every aspect of the project adheres to the highest quality benchmarks.
A Legacy of Experience and Agile Execution
With over 35 years of experience, Shroff Consulting Engineers has built a strong track record across the pharmaceutical, chemical, and petrochemical sectors. The company has successfully designed and delivered more than 250 projects across the globe, demonstrating its ability to handle diverse and complex assignments.
Today, it is capable of managing projects with investments ranging from ?100 crore to ?800 crore, offering EPCM services from concept design to mechanical completion.
Shroff has also bagged National Award for “Excellence in Consultancy Services” from ‘Consultancy Development Centre’ - Govt. Of India for Engineering & Project Management Consultancy Services for Inhalation Anesthetic Project for the Year 2006.
One of the defining features of Shroff’s operations is its ability to execute parallel engineering. This allows the company to begin engineering, procurement, and construction activities even as product development is underway in laboratories. Such an approach significantly reduces time-to-market, providing a competitive advantage to clients in a fast-paced industry.
The company has also invested in developing in-house software tools and comprehensive databases for various unit operations, equipment, and project types. These resources enhance design accuracy, improve efficiency, and support faster decision-making.
Shroff’s agile organizational structure enables it to handle multiple projects simultaneously while maintaining strong client relationships. This is reflected in its high rate of repeat business, with many clients continuing their association with the company for decades.
Future Growth and Strategic Vision
Looking ahead, Shroff Consulting Engineers is focused on expanding its presence and exploring new growth opportunities. The company is actively considering entry into the United States market through strategic partnerships, driven by increasing investments in domestic manufacturing in that region. This move aligns with global trends toward supply chain diversification and localized production.
In addition to pharmaceuticals, Shroff is exploring opportunities in emerging sectors such as nuclear energy, particularly in the development of small modular reactors. Within the pharmaceutical sector, the firm is preparing to support advancements in biopharma and novel drug manufacturing, which require highly specialized engineering capabilities.
While the adoption of technologies like artificial intelligence is still at an exploratory stage, Shroff is actively evaluating how such innovations can enhance its design processes and project outcomes.
Through its commitment to quality, innovation, and client-centric execution, Shroff Consulting Engineers continues to strengthen its position as a trusted partner in pharmaceutical engineering. As the industry evolves, the company remains focused on delivering world-class solutions that meet the demands of a rapidly changing global landscape.
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")